These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 24346072)

  • 1. Intravenous administration of bone marrow-derived multipotent mesenchymal stromal cells has a neutral effect on obesity-induced diabetic cardiomyopathy.
    Calligaris SD; Conget P
    Biol Res; 2013; 46(3):251-5. PubMed ID: 24346072
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intravenous administration of multipotent stromal cells prevents the onset of non-alcoholic steatohepatitis in obese mice with metabolic syndrome.
    Ezquer M; Ezquer F; Ricca M; Allers C; Conget P
    J Hepatol; 2011 Nov; 55(5):1112-20. PubMed ID: 21356258
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice.
    Ezquer FE; Ezquer ME; Parrau DB; Carpio D; Yañez AJ; Conget PA
    Biol Blood Marrow Transplant; 2008 Jun; 14(6):631-40. PubMed ID: 18489988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple intravenous infusions of bone marrow mesenchymal stem cells reverse hyperglycemia in experimental type 2 diabetes rats.
    Hao H; Liu J; Shen J; Zhao Y; Liu H; Hou Q; Tong C; Ti D; Dong L; Cheng Y; Mu Y; Liu J; Fu X; Han W
    Biochem Biophys Res Commun; 2013 Jul; 436(3):418-23. PubMed ID: 23770360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endovenous administration of bone-marrow-derived multipotent mesenchymal stromal cells prevents renal failure in diabetic mice.
    Ezquer F; Ezquer M; Simon V; Pardo F; Yañez A; Carpio D; Conget P
    Biol Blood Marrow Transplant; 2009 Nov; 15(11):1354-65. PubMed ID: 19822294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bone marrow mesenchymal stromal cells rescue cardiac function in streptozotocin-induced diabetic rats.
    Monnerat-Cahli G; Trentin-Sonoda M; Guerra B; Manso G; Ferreira AC; Silva DL; Coutinho DC; Carneiro-Ramos MS; Rodrigues DC; Cabral-da-Silva MC; Goldenberg RC; Nascimento JH; Campos de Carvalho AC; Medei E
    Int J Cardiol; 2014 Feb; 171(2):199-208. PubMed ID: 24374203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapy with mesenchymal stromal cells or conditioned medium reverse cardiac alterations in a high-fat diet-induced obesity model.
    Daltro PS; Barreto BC; Silva PG; Neto PC; Sousa Filho PHF; Santana Neta D; Carvalho GB; Silva DN; Paredes BD; de Alcantara AC; Freitas LAR; Couto RD; Santos RR; Souza BSF; Soares MBP; Macambira SG
    Cytotherapy; 2017 Oct; 19(10):1176-1188. PubMed ID: 28801055
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mesenchymal stromal cell-based therapies reduce obesity and metabolic syndromes induced by a high-fat diet.
    Lee CW; Hsiao WT; Lee OK
    Transl Res; 2017 Apr; 182():61-74.e8. PubMed ID: 27908750
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced stem cell engraftment and modulation of hepatic reactive oxygen species production in diet-induced obesity.
    Nyamandi VZ; Johnsen VL; Hughey CC; Hittel DS; Khan A; Newell C; Shearer J
    Obesity (Silver Spring); 2014 Mar; 22(3):721-9. PubMed ID: 23894091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice long-term high-fat diet feeding recapitulates human cardiovascular alterations: an animal model to study the early phases of diabetic cardiomyopathy.
    Calligaris SD; Lecanda M; Solis F; Ezquer M; Gutiérrez J; Brandan E; Leiva A; Sobrevia L; Conget P
    PLoS One; 2013; 8(4):e60931. PubMed ID: 23593350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mesenchymal stem cell therapy ameliorates diabetic hepatocyte damage in mice by inhibiting infiltration of bone marrow-derived cells.
    Nagaishi K; Ataka K; Echizen E; Arimura Y; Fujimiya M
    Hepatology; 2014 May; 59(5):1816-29. PubMed ID: 24375439
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of glucose and lipid metabolism by porcine adiponectin receptor 1-transgenic mesenchymal stromal cells in diet-induced obese mice.
    Lin YY; Chen CY; Lin Y; Chiu YP; Chen CC; Liu BH; Mersmann HJ; Wu SC; Ding ST
    Cytotherapy; 2013 Aug; 15(8):971-8. PubMed ID: 23732048
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human Obesity Attenuates Cardioprotection Conferred by Adipose Tissue-Derived Mesenchymal Stem/Stromal Cells.
    Yu S; Klomjit N; Jiang K; Zhu XY; Ferguson CM; Conley SM; Obeidat Y; Kellogg TA; McKenzie T; Heimbach JK; Lerman A; Lerman LO
    J Cardiovasc Transl Res; 2023 Feb; 16(1):221-232. PubMed ID: 35616881
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of bone marrow mesenchymal stem cells on hematopoietic recovery and acute graft-versus-host disease in murine allogeneic umbilical cord blood transplantation model.
    Li ZY; Wang CQ; Lu G; Pan XY; Xu KL
    Cell Biochem Biophys; 2014 Sep; 70(1):115-22. PubMed ID: 24696072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mesenchymal stem cells modified with miR-126 release angiogenic factors and activate Notch ligand Delta-like-4, enhancing ischemic angiogenesis and cell survival.
    Huang F; Zhu X; Hu XQ; Fang ZF; Tang L; Lu XL; Zhou SH
    Int J Mol Med; 2013 Feb; 31(2):484-92. PubMed ID: 23229021
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Placenta-Derived Adherent Stromal Cells Improve Diabetes Mellitus-Associated Left Ventricular Diastolic Performance.
    Van Linthout S; Hamdani N; Miteva K; Koschel A; Müller I; Pinzur L; Aberman Z; Pappritz K; Linke WA; Tschöpe C
    Stem Cells Transl Med; 2017 Dec; 6(12):2135-2145. PubMed ID: 29024485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of mesenchymal stromal cells on diabetic cardiomyopathy.
    Linthout SV; Spillmann F; Schultheiss HP; Tschöpe C
    Curr Pharm Des; 2011 Oct; 17(30):3341-7. PubMed ID: 21919875
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanotubular crosstalk with distressed cardiomyocytes stimulates the paracrine repair function of mesenchymal stem cells.
    Figeac F; Lesault PF; Le Coz O; Damy T; Souktani R; Trébeau C; Schmitt A; Ribot J; Mounier R; Guguin A; Manier C; Surenaud M; Hittinger L; Dubois-Randé JL; Rodriguez AM
    Stem Cells; 2014 Jan; 32(1):216-30. PubMed ID: 24115309
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cotransplanted bone marrow derived mesenchymal stem cells (MSC) enhanced engraftment of hematopoietic stem cells in a MSC-dose dependent manner in NOD/SCID mice.
    Kim DH; Yoo KH; Yim YS; Choi J; Lee SH; Jung HL; Sung KW; Yang SE; Oh WI; Yang YS; Kim SH; Choi SY; Koo HH
    J Korean Med Sci; 2006 Dec; 21(6):1000-4. PubMed ID: 17179676
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocardial CXCR4 expression is required for mesenchymal stem cell mediated repair following acute myocardial infarction.
    Dong F; Harvey J; Finan A; Weber K; Agarwal U; Penn MS
    Circulation; 2012 Jul; 126(3):314-24. PubMed ID: 22685115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.